BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8249276)

  • 1. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function.
    Runkel L; Fischer M; Schaller H
    Virology; 1993 Dec; 197(2):529-36. PubMed ID: 8249276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function.
    Misra KP; Mukherji A; Kumar V
    Virus Res; 2004 Oct; 105(2):157-65. PubMed ID: 15351489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
    Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
    Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
    Kim YK; Junn E; Park I; Lee Y; Kang C; Ahn JK
    Biochem Biophys Res Commun; 1999 Apr; 257(3):759-65. PubMed ID: 10208856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
    Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
    Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
    Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
    Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct.
    Lin Y; Nomura T; Yamashita T; Dorjsuren D; Tang H; Murakami S
    Cancer Res; 1997 Nov; 57(22):5137-42. PubMed ID: 9371515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
    Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
    Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D; Dumenco LL; Pierce RH; Fausto N
    Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
    Derse D; Newbold SH
    Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
    Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes.
    Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M
    Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protooncogene c-jun by the X protein of hepatitis B virus.
    Twu JS; Lai MY; Chen DS; Robinson WS
    Virology; 1993 Jan; 192(1):346-50. PubMed ID: 8390762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein partially substitutes for E1A transcriptional function during adenovirus infection.
    Schaack J; Maguire HF; Siddiqui A
    Virology; 1996 Feb; 216(2):425-30. PubMed ID: 8607273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.